InvestorsHub Logo

frenchbroad

12/29/23 5:24 PM

#401073 RE: sunspotter #401071

The same silly boring lies. But it is all you can offer.
You want to say Brilacidin is not a safe drug. This is false. It is a super old argument and it remains false.
You say Brilacidin makes dangerous hypertension.
53 persons received 0.6mg/kg Brilacidin one dose in the ABSSSI trial.
3.8% had a hypertension event.
50 persons received Daptomycin 7 days in the ABSSSI trial.
10.0% had a hypertension event.

Humans received Brilacidin in the mouth and the rectum and in the vein in clinical trials. Each time was safe. After the ABSSSI trial the USA FDA was okay for persons sick and vulnerable to receive Brilacidin in the blood to test against the virus.

Also important for any one: Brilacidin 0.6mg/kl for one wee dose had the same effect to fight ABSSSI than Daptomycin for 7 days.
Which of these is more dangerous for the sick person?
1> Receive 1 dose Brilacidin in the vein and go home from the hospital.
2> Receive Daptomycin and stay in hospital 7 days with a needle in the arm.

Maybe the hospital is where they got the MRSA before.

And I see you ignore the Treatment Relation Adverse Event number. If you exclude numbing and tingling 26% of persons with Daptomycin had a TRAE. Those with Brilacidin had much less. Those with one dose Brilacidin had only 7.5%. I am not worried for numbing and tingling. Many safe drugs today cause this for a short time.

Brilacidin does not help different malady in humans? Pfft....wrong again.
Brilacidin for ABSSSI in human Phase 2 trial: Success
Brilacidin for Oral Mucositis in human Phase 2 trial: Success
Brilacidin for Ulcerative Proctitis in human Phase 2 trial: Success
Brilacidin in pre-clinic tests for anti-virus and anti-fungus and anti-inflammation: Success
All these facts are super easy to find and verify.

I know you will continue to say Brilacidin is dangerous. It really is the only argument you have against Brilacidin science even if it is so easy to see false.